WA
GILD icon

Westport Advisers’s Gilead Sciences GILD Stock Holding History

Westport Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$7.92M Hold
95,000
– – 1.46% 25
2016
Q1 		$8.73M Hold
95,000
– – 1.36% 25
2015
Q4 		$9.61M Hold
95,000
– – 1.39% 26
2015
Q3 		$9.33M Hold
95,000
– – 1.26% 28
2015
Q2 		$11.1M Buy
+95,000
New +$10.4M 1.21% 29

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Westport Advisers's GILD Position: Q2 2016 in Review

Westport Advisers held its Gilead Sciences (GILD) position steady in Q2 2016 at 95,000 shares worth $7.92M. The position accounts for 1.46% of the portfolio, ranked #25.

Westport Advisers first reported a position in GILD in Q2 2015 and has held it in 5 quarters since. The position peaked at $11.1M in Q2 2015. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Westport Advisers held 95,000 shares of Gilead Sciences worth $7.92M as of Q2 2016.
  • Westport Advisers left its Gilead Sciences share count unchanged in Q2 2016.
  • Gilead Sciences made up 1.46% of Westport Advisers's portfolio in Q2 2016, its #25 holding.
  • Westport Advisers first reported a position in Gilead Sciences in Q2 2015 and has held it in 5 quarters since.
  • Westport Advisers's Gilead Sciences position peaked at $11.1M in Q2 2015.
  • 1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Westport Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.